Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Association Between Dietary Magnesium Intake With Serum Brain-Derived Neurotrophic Factor (Bdnf) and Adropin Levels and Metabolic Health Status in Iranian Adults Publisher Pubmed



Rahimi M1, 2 ; Tirani SA1, 2 ; Shahdadian F1, 3 ; Hajhashemy Z1, 2 ; Rouhani P4 ; Mohammadi S5 ; Mokhtari E1, 2 ; Saneei P2
Authors
Show Affiliations
Authors Affiliations
  1. 1. Student Research Committee, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Department of Community Nutrition, School of Nutrition and Food Science, Nutrition and Food Security Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Department of Clinical Nutrition, School of Nutrition and Food Science, Nutrition and Food Security Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia
  5. 5. Department of Community Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran

Source: Biological Trace Element Research Published:2024


Abstract

Given the sparse conclusive findings regarding the association of magnesium intake with metabolic health status and limited evidence relating magnesium intake to metabolic biomarkers, our objective was to evaluate the association of metabolic health status, adropin, and brain-derived neurotrophic factor (BDNF) in relation to dietary magnesium intake. In this cross-sectional study, 527 male and female adults were investigated in Isfahan City. The data regarding usual dietary intakes were gathered using a valid and reliable 168-item food frequency questionnaire. Biochemical variables, anthropometric indices, and blood pressure were assessed following standard methods. The criteria suggested by Wildman et al. were used to classify participants as metabolically unhealthy (MU) and metabolically healthy (MH). Moderate magnesium intake was associated with 71% reduced odds of MU (OR T2 vs. T1 = 0.29; 95% CI: 0.12–0.70). In the stratified analysis, the inverse association between moderate intake of magnesium and MU was seen only in overweight/obese subjects but not in normal-weight ones. A significant difference was found in serum levels of adropin between the first and second tertile of dietary magnesium intake among overweight/obese subjects (62.74 ± 4.99 vs. 50.13 ± 2.54, P = 0.03). After adjustment for potential covariates, this association became attenuated (59.06 ± 3.47 vs. 50.02 ± 3.64, P = 0.20). No statistically significant link was obtained between dietary intake of magnesium and circulating BDNF levels. Moderate dietary intake of magnesium may exert beneficial effects on metabolic health and serum levels of adropin, especially in obese/overweight individuals. Further prospective studies will be required to approve our findings. © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2024.
Experts (# of related papers)
Other Related Docs
23. Risk of Diabetes According to the Metabolic Health Status and Degree of Obesity, Diabetes and Metabolic Syndrome: Clinical Research and Reviews (2017)
34. Dietary Intake of Minerals in the Patients With Stroke, Journal of Research in Medical Sciences (2013)
38. The Association Between Carbohydrate Intake and Metabolic Syndrome, Journal of Isfahan Medical School (2011)
39. The Epigenetic Overlap Between Obesity and Mood Disorders: A Systematic Review, International Journal of Molecular Sciences (2020)
45. Does Water Hardness Have Preventive Effect on Cardiovascular Disease?, International Journal of Preventive Medicine (2014)